External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
NCT05864599
·
clinicaltrials.gov ↗
UNKNOWN
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-muscle-invasive Bladder Cancer
Sponsor
Pharmalink